Antibacterial activity of Moringa oleifera leaves extract against vancomycin resistant Enterococcus faecalis Clinical Isolates
Year: 2026
Type: article
Abstract: Vancomycin-resistant Enterococcus faecalis (VRE) is a high-priority pathogen with limited treatment options. Medicinal plants offer promising alternatives due to their multi-target mechanisms. This study evaluated the antibacterial activity of Moringa oleifera leaf extract against VRE clinical isolates. Three Clinical isolates were phenotypically confirmed using Gram staining and biochemical tests. Vancomycin resistance was determined by disk diffusion. Ethanolic leaf extract was prepared, screened for phytochemical compounds and tested for antibacterial activity using agar well diffusion, broth microdilution (MIC), and minimum bactericidal concentration (MBC) assays. All the E. faecalis isolates (100%) were vancomycin-resistant (≤14 mm). Phytochemical screening of the M. oleifera ethanolic leaf extract revealed the presence of alkaloids, flavonoids, tannins, saponins, and steroids. The extract exhibited concentration-dependent inhibition against the VRE isolates with zones of inhibition ranging from 9–11 mm (25 mg/mL) to 20–24 mm (200 mg/mL). The MIC was 6.25 mg/mL and MBC was 12.5 mg/mL (MBC/MIC ratio = 2.0), indicating bactericidal activity. The M. oleifera leaf extract demonstrated significant bactericidal activity against phenotypically confirmed VRE, supporting its potential as an alternative therapeutic agent. Further studies on compound isolation, synergy, and in vivo efficacy are recommended.
DOI: 10.70882/jpas00579
Language: English
Subfield: Plant Science
Domain: Life Sciences
Keywords: Moringa oleifera, vancomycin-resistant Enterococcus faecalis, antibacterial activity, plant extracts, ethanolic leaf extract, minimum inhibitory concentration, minimum bactericidal concentration, phytochemical screening, bactericidal activity, vancomycin resistance, clinical isolates, medicinal plants
Open Access status: hybrid
OpenAlex ID: W7215942579
